Brief: Bioarctic Says Novartis Terminates Option, Collaboration And License Agreement With Bioarctic
Mon 20:32
BRIEF-Bioarctic Says Novartis Terminates Option, Collaboration And License Agreement With Bioarctic Nov 2 (Reuters) - BioArctic AB (publ) BIOAb.ST:
BIOARCTIC AB (PUBL) - NOVARTIS TERMINATES OPTION, COLLABORATION AND LICENSE AGREEMENT WITH BIOARCTIC
BIOARCTIC AB (PUBL) - TO RETAIN $30 MILLION UPFRONT PAYMENT AND RECOGNIZE REMAINING REVENUE IN 2026
BIOARCTIC AB (PUBL) - TERMINATION IS RESULT OF A NOVARTIS DECISION TO DISCONTINUE PROGRAM, UNRELATED TO BIOARCTIC'S BRAINTRANSPORTER TECHNOLOGY
Source text: ID:nWkrQRvB1
Further company coverage: [BIOAb.ST]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Novartis AG
See all newsSwiss pharma industry behind in technology and clinical trials, index shows
European shares rise as Democrats take US Congress, Novo Nordisk surges
European shares rise as Democratic sweep lifts clean energy, bank stocks
Europe set to open lower as Democratic sweep fuels AI regulation fears
Brief: Bioarctic Says Novartis Terminates Option, Collaboration And License Agreement With Bioarctic